Compare NIO & ENSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NIO | ENSG |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Hospital/Nursing Management |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 10.5B |
| IPO Year | 2018 | 2007 |
| Metric | NIO | ENSG |
|---|---|---|
| Price | $4.94 | $213.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $6.73 | ★ $202.60 |
| AVG Volume (30 Days) | ★ 48.0M | 458.5K |
| Earning Date | 03-20-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.12% |
| EPS Growth | N/A | ★ 14.06 |
| EPS | N/A | ★ 5.84 |
| Revenue | ★ $10,189,444,895.00 | $5,057,841,000.00 |
| Revenue This Year | $33.07 | $14.95 |
| Revenue Next Year | $51.24 | $9.05 |
| P/E Ratio | ★ N/A | $36.53 |
| Revenue Growth | 14.90 | ★ 18.71 |
| 52 Week Low | $3.02 | $118.73 |
| 52 Week High | $8.02 | $216.92 |
| Indicator | NIO | ENSG |
|---|---|---|
| Relative Strength Index (RSI) | 50.87 | 82.15 |
| Support Level | $4.73 | $167.43 |
| Resistance Level | $5.11 | $216.92 |
| Average True Range (ATR) | 0.22 | 6.42 |
| MACD | 0.05 | 4.42 |
| Stochastic Oscillator | 60.02 | 97.75 |
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.